Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · IEX Real-Time Price · USD
1.220
+0.010 (0.83%)
At close: Jul 2, 2024, 3:59 PM
1.340
+0.120 (9.84%)
After-hours: Jul 2, 2024, 7:46 PM EDT
Bone Biologics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Bone Biologics.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Bone Biologics.
Recommendation Trends
| Rating | Jan '23 | Feb '23 | Mar '23 | Apr '23 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| EF Hutton | EF Hutton | Strong Buy Reiterates $540 | Strong Buy | Reiterates | $540 | +44,162.30% | Apr 13, 2023 |
| EF Hutton | EF Hutton | Strong Buy Reiterates $540 | Strong Buy | Reiterates | $540 | +44,162.30% | Apr 3, 2023 |
| EF Hutton | EF Hutton | Strong Buy Initiates $540 | Strong Buy | Initiates | $540 | +44,162.30% | Oct 18, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.43
from -34.01
EPS Next Year
-4.94
from -5.43
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -5.59 | -5.08 | -5.11 |
| Avg | -5.43 | -4.94 | -4.97 |
| Low | -5.21 | -4.74 | -4.77 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.